CD9 and acute promyelocytic leukemia: As illustrated in Fig. 6i, the consistent downregulation of several stemness-associated CD markers (CD200 and CD9) and TFs (HHEX and NFATC2) was not observed in APL patients with early death (Supplementary Data 11).